Loading…
This event has ended. Visit the official site or create your own event on Sched.
Wednesday, September 25
 

8:00am PDT

Registration and Networking Breakfast
Wednesday September 25, 2024 8:00am - 8:45am PDT
Wednesday September 25, 2024 8:00am - 8:45am PDT
Grand Ballroom salons EFGH

8:45am PDT

Chairperson’s Opening Remarks
Wednesday September 25, 2024 8:45am - 9:00am PDT
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Wednesday September 25, 2024 8:45am - 9:00am PDT
Grand Ballroom ABCD

9:00am PDT

Driving Diversity and Patient-Centric Innovation: The Transformative Role of Medical Affairs
Wednesday September 25, 2024 9:00am - 9:30am PDT
  • Explore the essential benchmarks for building high-performing Medical Affairs teams throughout the drug development process
  • Discuss effective strategies for reflecting corporate values in Medical Affairs initiatives to ensure alignment with organizational mission and ethics
  • Highlight how Medical Affairs can drive efforts in diversity, inclusion, and patient-centricity to enhance overall healthcare outcomes and patient engagement
Speakers
avatar for Richey Neuman, M.D., M.P.H.

Richey Neuman, M.D., M.P.H.

Vice President of Medical Affairs, Cytokinetics
Richey serves as Vice President of Medical Affairs, and joined Cytokinetics in February 2020.Prior to Cytokinetics, Richey held Vice President of Medical Affairs positions at MyoKardia, Portola, Hyperion, and Teva. Before joining the pharmaceutical industry in 2006, Richey was on... Read More →
Wednesday September 25, 2024 9:00am - 9:30am PDT
Grand Ballroom ABCD

9:30am PDT

Mastering AI in Medical Affairs: From Strategy to Impact
Wednesday September 25, 2024 9:30am - 10:00am PDT
  • Acknowledge where most medical affairs teams currently stand in their journey towards the ideal state of AI integration, comparing the "dreamland" vision with the practical realities of today's processes and technologies.
  • Discuss the real-world applications and key lessons learned from Gen AI's rapid evolution over the past two years, including how AI has been utilized in various aspects of medical affairs, such as field insights, lit review, med education , all contributing to strategic insights.
  • Explore actionable steps teams can take today to transform insights into impactful strategies, emphasizing the importance of selecting the right tools—whether internal solutions like enterprise GPT or external vendors—and implementing change management processes to achieve desired outcomes
Speakers
avatar for Vera Kutsenko

Vera Kutsenko

Founder & CEO, Atrix AI
Vera Kutsenko is the CEO of Atrix AI. Atrix helps medical affairs teams measure the impact of their medical strategy across field, med education, med info, and more. Vera brings over 10 years of experience in the technology industry across AI, global and secure distributed systems... Read More →
avatar for Carl de Luca, Ph.D.

Carl de Luca, Ph.D.

Director, Insights and Data Analytics, Regeneron
Carl de Luca, PhD, is a distinguished professional in the field of medical affairs with a robust background in oncology. He earned his PhD from Columbia University, where he developed a strong foundation in medical research and scientific inquiry. Dr. de Luca began his career in... Read More →
Wednesday September 25, 2024 9:30am - 10:00am PDT
Grand Ballroom ABCD

10:00am PDT

Driving Value from Development Through Delivery: The Essential Role of Medical Affairs in Bridging Clinical and Commercial Divides
Wednesday September 25, 2024 10:00am - 10:45am PDT
  • Examine how medical affairs sits as the crucial third pillar between clinical and commercial functions, harnessing the strengths of both sides to deliver enhanced value to stakeholders 
  • Explore the dynamics of successful collaborations between medical and commercial teams, emphasizing the importance of mutual understanding, communication and shared goals 
  • Understand the significance of defining success metrics, tracking collabortative efforts, and fostering a culture of innovation within regulated environments to drive continual improvement 
Moderators
avatar for Patricia Novy

Patricia Novy

Vice President of Medical Affairs, Dynavax
Dr. Novy joined Dynavax in 2021 and currently serves as Vice President, Medical Affairs. She comes to the company with more than 10 years of experience in the vaccines field. Dr. Novy joined Dynavax from Moderna, where she was Senior Director, Global Medical Affairs, responsible for... Read More →
Speakers
avatar for Mancia Ko, PharmD, MBA

Mancia Ko, PharmD, MBA

Vice President Medical Affairs, Collegium Pharmaceutical
 Mancia Ko has diverse experience in Medical Affairs, Medical Communications, Regulatory Affairs, Market Access, and Business Development. She is currently the Vice President of Medical Affairs at Collegium Pharmaceutical, where her strategic thinking and agility have been transformative... Read More →
avatar for Scott McConnell

Scott McConnell

Vice President Clinical Science and Pharmacovigilance, Xilio Therapeutics
Scott McConnell, Pharm.D. is currently the VP of Clinical Sciences and Pharmacovigilance at Xilio Therapeutics. He has spent the last 19 years in various roles within Medical Affairs at Cubist, Merck, Chiasma (Amryt), Alkermes and Venatorx. Prior to industry he spent several years... Read More →
avatar for April Thompson

April Thompson

Vice President, Global Medical Affairs, Otsuka
April Thompson is currently the Vice President of Global Medical Affairs at Otsuka.  April has a career spanning two decades in the pharmaceutical industry. She has worked across a range of therapeutic areas, including Psychiatry, Neurology, Immunology, Hepatology, and Dermatology... Read More →
Wednesday September 25, 2024 10:00am - 10:45am PDT
Grand Ballroom ABCD
  General Session
  • QTAG MASSW24FS

10:45am PDT

Networking Break
Wednesday September 25, 2024 10:45am - 11:15am PDT
Wednesday September 25, 2024 10:45am - 11:15am PDT
Grand Ballroom salons EFGH

10:45am PDT

1:1 Curated Meetings
Wednesday September 25, 2024 10:45am - 12:00pm PDT
Wednesday September 25, 2024 10:45am - 12:00pm PDT
Rancho Santa Fe Ballroom I&II

11:15am PDT

Roundtables
Wednesday September 25, 2024 11:15am - 12:00pm PDT
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Avni Patel, Senior Director, Medical Affairs, Jazz Pharmaceuticals 

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 
Speakers
avatar for Avni Patel, PharmD

Avni Patel, PharmD

Senior Director, Medical Affairs, Jazz Pharmaceuticals
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 11:15am - 12:00pm PDT
Grand Ballroom ABCD

12:00pm PDT

Integrating Medical Affairs and Patient Advocacy in Early-Stage Biotech: A Blueprint for Agile Drug Development
Wednesday September 25, 2024 12:00pm - 12:30pm PDT
Speakers
avatar for Maria Candida Vila, PharmD, MSPH, Ph.D.

Maria Candida Vila, PharmD, MSPH, Ph.D.

Director of Medical Affairs, Encoded Therapeutics
Dr. Maria Candida Vila has over a decade of experience in the medical and scientific arenas. She is currently Director of Medical Affairs at Encoded Therapeutics, where she plays a key role in advancing gene therapies for pediatric CNS disorders. Since joining the company in April... Read More →
Wednesday September 25, 2024 12:00pm - 12:30pm PDT
Grand Ballroom ABCD

12:30pm PDT

Networking Lunch
Wednesday September 25, 2024 12:30pm - 1:30pm PDT
Wednesday September 25, 2024 12:30pm - 1:30pm PDT
Grand Ballroom salons EFGH

1:30pm PDT

Quantifying Impact: Unveiling Metrics That Resonate with Stakeholders
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
  • Discuss the importance of identifying and tailoring metrics to the specific needs and perspectives of various stakeholders within the healthcare ecosystem - both internally, including executive management and cross-functional partners, as well as externally, including providers, payors, and patients. 
  • Highlight the significance of clinically relevant metrics to quantify the impact of Medical Affairs strategic and tactical activities, e.g., educational, and one-on-one field engagement activities that potentially reflect improvement by the medical community's understanding of treatment options and the diagnosis of the therapeutic area. 
  • Explore potential real-world data sources, e.g., electronic health records, claims data, and patient-reported outcomes, in quantifying the impact of Medical Affairs activities. Discuss analytics for effectively capturing, analyzing, and interpreting real-world evidence to potentially explain the meaning of insights and to drive better decision-making around Medical Affairs resource allocation. 
Speakers
avatar for Daniel Snyder, Ph.D.

Daniel Snyder, Ph.D.

Senior Vice President, Head of Medical Affairs, Biopharma & Women’s Health, Sumitomo Pharma America, Inc.
Over the past 30 years in the pharmaceutical industry, Daniel Snyder, PhD has delivered Global Medical Affairs excellence during all stages of a drug’s lifecycle and established a record of building Medical Affairs functions from the ground up. He has expertise in building and leading... Read More →
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
Grand Ballroom ABCD
  General Session
  • QTAG MASSW24FS

2:00pm PDT

Optimizing Medical Affairs Integration: Strategies for Building and Scaling Throughout the Development Cycle
Wednesday September 25, 2024 2:00pm - 2:45pm PDT
  • Discuss key stages in drug development where early integration of Medical Affairs teams can optimize product strategy and market access
  • Identify effective strategies for scaling medical affairs capabilities
  • Explore ways to enhance cross-functional collaboration across the product lifecycle
Moderators
avatar for Catherine Ross, PharmD

Catherine Ross, PharmD

Head of Field Medical Affairs, Orca Bio
Catherine Ross is a dynamic, innovative, and compassionate leader who spent almost 10 years as a Pediatric Hematology/Oncology Pharmacist at Children's Healthcare of Atlanta before transitioning to a career in Medical Affairs. She spent 5.5 years at Jazz Pharmaceuticals as a Medical... Read More →
Speakers
avatar for Andrea Goldstein

Andrea Goldstein

Senior Vice President, Global Medical and Scientific Affairs, Mirum Pharmaceuticals
Andrea Goldstein is a pharmaceutical industry veteran with more than 20 years of experience,building medical affairs capabilities, leading drug launches, and bringing new therapies to patientsat both biotech start-ups and large pharmaceutical companies.Andrea has extensive clinical... Read More →
avatar for Eleonora Goldberg, Ph.D.

Eleonora Goldberg, Ph.D.

Vice President Medical Affairs, Arrowhead Pharmaceuticals
Eleonora has extensive experience in Medical Affairs, having strategically developed and transformed Medical Affairs teams at the local, regional, and global level. She has led matrixed and dynamic teams, partnering cross-functionally to enhance the impact and scientific knowledge... Read More →
avatar for Nick Giafis, Ph.D.

Nick Giafis, Ph.D.

Vice President, Head of Medical Affairs, Kura Oncology
Nick Giafis is currently Vice President and Head of Medical Affairs at Kura Oncology. He has over 18 years of experience working in medical affairs roles of progressive responsibility. Previously, he worked at Kronos Bio where he created and led the medical organization. Before Kronos... Read More →
Wednesday September 25, 2024 2:00pm - 2:45pm PDT
Grand Ballroom ABCD

2:45pm PDT

Empowering Medical Affairs: Streamlining Operations with Technology
Wednesday September 25, 2024 2:45pm - 3:15pm PDT
  • Automate for Efficiency: Implementing software solutions can automate repetitive tasks, enabling medical affairs teams to prioritize strategic initiatives and value-added activities.
  • Collaborate Seamlessly: Advanced software fosters seamless collaboration among both internal teams and external stakeholders, enhancing communication and optimizing project timelines.
  • Increase Productivity: Leveraging software capabilities allows teams to efficiently manage increased publication outputs and medical information requests, while simultaneously reducing errors and ensuring compliance


Speakers
avatar for David A. Mays, PharmD, MBA

David A. Mays, PharmD, MBA

Global Publications Director, Neuromodulation
avatar for Peter Herout, PharmD

Peter Herout, PharmD

Associate Director, Scientific Communication, Esperion
avatar for Michelle L. Chernock, Ph.D.

Michelle L. Chernock, Ph.D.

Founder and CEO, Leaders in Medical Affairs
Michelle L. Chernock, PhD, is the founder of Leaders in Medical Affairs and MSL University. With more than 20 years of experience in the pharmaceutical industry – from startups to multinationals – Michelle specializes in helping medical affairs leaders develop their careers and... Read More →
Wednesday September 25, 2024 2:45pm - 3:15pm PDT
Grand Ballroom ABCD

3:15pm PDT

Networking Break
Wednesday September 25, 2024 3:15pm - 3:45pm PDT
Wednesday September 25, 2024 3:15pm - 3:45pm PDT
Grand Ballroom salons EFGH

3:15pm PDT

1:1 Curated Meetings
Wednesday September 25, 2024 3:15pm - 4:30pm PDT
Wednesday September 25, 2024 3:15pm - 4:30pm PDT
Rancho Santa Fe Ballroom I&II

3:45pm PDT

Roundtables
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Jim Wilkinson, Ph.D., US Medical Lead, Medical Affairs & Evidence Generation, Argenx

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 


Speakers
avatar for Jim Wilkinson, Ph.D.

Jim Wilkinson, Ph.D.

US Medical Lead, Medical Affairs & Evidence Generation, Argenx
Jim Wilkinson, Ph.D. is currently US Medical Lead, Medical Affairs & Evidence Generation with argenx.Jim is an experienced and innovative leader in global and US Medical Affairs, with over 22 years in the biopharma industry. He has worked in several therapeutic areas while also launching... Read More →
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
Grand Ballroom ABCD

4:30pm PDT

From Strategy to Execution: A Blueprint for Launch Success
Wednesday September 25, 2024 4:30pm - 5:20pm PDT
  • Discuss the importance of early collaboration across various functions within the organization, emphasizing how it enhances launch success 
  • Highlight specific strategies and examples of successful integration efforts during different phases of product launch 
  • Examine the importance of aligning launch strategies with therapeutic goals, market dynamics, and available data to maximize MSL effectiveness 
  • Explore effective strategies for measuring success in product launches, including KPI's and metrics 


Moderators
avatar for Arthur Chan, PhD, MBA

Arthur Chan, PhD, MBA

Vice President of Medical Affairs, Tarsus Pharmaceuticals
Arthur Chan is an innovative and respected medical affairs leader with 20 years of experience in pharmaceuticals and medical devices. He has successfully built teams and launched products in many therapeutic areas with a decade of focus in eyecare. Arthur is currently vice president... Read More →
Speakers
avatar for Gail Larkins

Gail Larkins

Executive Director, Global Medical Operations, BioCryst Pharmaceuticals
Gail Larkins is a medical professional with more than 20 years of experience in the pharmaceutical industry. She has held positions in clinical development, patient advocacy and Medical Affairs at Biotech start-ups and large pharmaceutical companies. Gail is an accomplished Medical... Read More →
avatar for Bob Numerof

Bob Numerof

Vice President, Medical Affairs, ALX Oncology
Bob Numerof is currently the Vice President of Medical Affairs at ALX Oncology. Prior to this role at ALX, he has had a number of positions in both small and large pharmaceutical companies which spanned the full scope of medical affairs activities and included both in-house and field-based... Read More →
avatar for Andrea Zider, Ph.D.

Andrea Zider, Ph.D.

Vice President Medical Brand, Medical Affairs, BridgeBio
avatar for Daphne Dodson, Ph.D.

Daphne Dodson, Ph.D.

EVP, Chief Strategy Officer, PIXACORE
avatar for Vanessa Jacobsen, PharmD

Vanessa Jacobsen, PharmD

Senior Director, Field Medical Affairs – Hematology, Regeneron
Vanessa Jacobsen is the Senior Director, Hematology Field Medical Affair at Regeneron.  In her role, Vanessa is responsible for providing leadership in developing and implementing the hematology field medical engagement strategy. Vanessa is a seasoned leader in assessment, development... Read More →
Wednesday September 25, 2024 4:30pm - 5:20pm PDT
Grand Ballroom ABCD

5:20pm PDT

Chairperson’s Closing Remarks
Wednesday September 25, 2024 5:20pm - 5:30pm PDT
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Wednesday September 25, 2024 5:20pm - 5:30pm PDT
Grand Ballroom ABCD

5:30pm PDT

Cocktail Reception
Wednesday September 25, 2024 5:30pm - 6:30pm PDT
Wednesday September 25, 2024 5:30pm - 6:30pm PDT
Grand Ballroom salons EFGH
 
Thursday, September 26
 

8:00am PDT

Networking Breakfast
Thursday September 26, 2024 8:00am - 9:00am PDT
Thursday September 26, 2024 8:00am - 9:00am PDT
Grand Ballroom salons EFGH

9:00am PDT

Chairperson’s Opening Remarks
Thursday September 26, 2024 9:00am - 9:15am PDT
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Thursday September 26, 2024 9:00am - 9:15am PDT
Grand Ballroom ABCD

9:15am PDT

Keynote: Enhancing Health Equity Through Collaborative Healthcare: Leveraging Multi-Stakeholder Partnerships for Improved Health Outcomes for All Patients
Thursday September 26, 2024 9:15am - 9:45am PDT
  • Explore the importance of multi-stakeholder collaboration in redressing the inequity that exists in healthcare globally to improve health outcomes, and the benefits of bringing together diverse perspectives, expertise, and resources from various sectors to effectively tackle complex health challenges 
  • Discuss the real value of collaborative programs in identifying at-risk underserved populations, increasing awareness of their health needs and treatment options, and implementing programs that reduce disparities in healthcare access 
  • Learn about Amgen's dedication to partnering with others in the healthcare ecosystem to achieve common goals addressing major health challenges and reaching patients with the greatest need



Speakers
avatar for Darryl Sleep

Darryl Sleep

Head Global Public Health, Amgen
Darryl Sleep, M.D., is the Head of Global Public Health within the Office of the Chief Medical Officer. Global Public Health focuses on Access to Healthcare, Clinical Trial Diversity and Representation, and the advancement of health equity globally. Dr. Sleep has over 40 years... Read More →
Thursday September 26, 2024 9:15am - 9:45am PDT
Grand Ballroom ABCD
  General Session
  • QTAG MASSW24FS

9:45am PDT

Navigating the Path to Omnichannel Integration in Medical Affairs-
Thursday September 26, 2024 9:45am - 10:30am PDT
  • Explore the role of data analytics in shaping customer engagement models and strategies, driving insights to tailor communication approaches and optimize engagement across diverse channels 
  • Discuss methods to streamline content development across multiple channels, ensuring adaptability, effectiveness, and consistency in messaging to enhance customer journey experiences 
  • Delve into practical approaches for implementing omnichannel strategies in scientific communication, navigating the complexities of multi-channel engagement to deliver cohesive and impactful messaging 
Speakers
avatar for Dalila Masic, PharmD

Dalila Masic, PharmD

Director of Medical Omnichannel, Sanofi
Dalila Masic is the Director of Medical Omnichannel for North America General Medicines at Sanofi. She drives the transformation of the medical omnichannel strategy, while integrating AI and digital innovations across the medical portfolio. Dalila holds a Doctor of Pharmacy degree... Read More →
avatar for Shivani Desai

Shivani Desai

Digital Strategy Implementation Lead, GSK
Shivani has comprehensive experience at GSK Global Digital, Data, and Tech, specializing in Product Innovation, Product Management, and Business Partnership across multiple Therapeutic Areas. She has been instrumental in delivering multiple novel technology solutions, forming and... Read More →
avatar for Ajit Kulkarni, PhD

Ajit Kulkarni, PhD

Sr. Dir, Medical Digital Engagement, Pfizer
Ajit is a leader at the intersection of business, digital, and medical science. Ajit drives specific global channel strategies, communication, and operations for Pfizer's Medical Affairs, developing and implementing key transformational initiatives at scale across for all medical... Read More →
avatar for Sandy Donaldson

Sandy Donaldson

CEO & Co-Founder, Impiricus
Sandy Donaldson is a healthcare leader with deep experience in advising and leading change with the world’s leading healthcare brands and organizations. He is currently the CEO & Co-Founder of Impiricus - focused on supporting HCPs in their clinical practice and provide Pharma... Read More →
Thursday September 26, 2024 9:45am - 10:30am PDT
Grand Ballroom ABCD

10:30am PDT

Networking Break
Thursday September 26, 2024 10:30am - 11:00am PDT
Thursday September 26, 2024 10:30am - 11:00am PDT
Grand Ballroom salons EFGH

11:00am PDT

Mapping the Digital Landscape: Showcasing Value and Embracing Transformation in Medical Affairs
Thursday September 26, 2024 11:00am - 11:45am PDT
  • Explore how AI technologies can streamline workflows, optimize resource allocation, and enhance operational efficiency within medical affairs departments 
  • Dive into the concept of generative AI and its potential impact on medical affairs 
  • Discuss the opportunities and challenges associated with generative AI, such as ensuring accuracy, maintaining regulatory compliance, and addressing ethical considerations 
  • Examine the infrastructure, resources, and expertise required to effectively implement new digital technologies within medical affairs organizations 
Moderators
avatar for Jonathan Ploeger

Jonathan Ploeger

Director, National Team Lead Health Evidence and Outcomes Liaisons, Genmab
Jonathan Ploeger, Director and National Team Lead for Health Evidence and Outcomes Liaisons, has over a decade of clinical, research, and biotech industry experience, including over six years of distinguished leadership in Medical Affairs. His extensive experience includes executing... Read More →
Speakers
avatar for Rishi Ohri

Rishi Ohri

Senior Director, Digital Excellence, Medical Affairs, Astellas
Rishi Ohri is the Head Global Medical Affairs Digital Excellence at Astellas Pharma.   He is committed to enabling Medical Affairs with new innovation and capabilities that optimize scientific exchange.   Rishi has been with Astellas for over 16 years and specializing in Medical... Read More →
avatar for Melanie Smith

Melanie Smith

Head, Medical Affairs Digital and Technology,, GSK
Melanie Smith is Head of Digital, Data, and Technology for US Medical Affairs at GSK. In this role, she is responsible for developing and implementing key tech enablers that support GSK’s modern Medical Affairs organization. Prior to that, she led Research & Insights at Evidation... Read More →
avatar for Vandana Grover

Vandana Grover

Senior Director, Head Digital Strategy and Innovation | Global & US Medical Affairs | Oncology, Eisai
Vandana Grover has over fifteen years of pharmaceutical, biotech, and academic experience having worked in the fields of oncology and interventional oncology across a variety of roles within Medical Affairs. Vandana is currently the Sr. Director for Digital Strategy and Innovation... Read More →
Thursday September 26, 2024 11:00am - 11:45am PDT
Grand Ballroom ABCD

11:45am PDT

Leveraging Technology and Innovative Tools for Enhanced MSL Effectiveness
Thursday September 26, 2024 11:45am - 12:30pm PDT
  • Explore how AI can empower MSL's to efficiently navigate vast amounts of data and extract actionable insights. 
  • Discuss the benefits of AI-driven tools in filtering, analyzing, and synthesizing scientific information to identify relevant trends, opportunities & challenges 
  • Examine best practices for leveraging social media listening tools to gather real-time insights, monitor conversations, and identify emerging trends in healthcare conversations 
  • Identify the role of MSLs in leveraging social media platforms to engage with healthcare professionals, patients, and other stakeholders, fostering collaborative relationships and driving thought leadership 
  • Highlight innovative approaches for utilizing technology to streamline communication, collaboration, and knowledge sharing among MSL teams and cross-functional stakeholders 
Moderators
avatar for Jason Beliakoff, Ph.D.

Jason Beliakoff, Ph.D.

Executive Director, U.S. Field Medical Affairs, Incyte
Jason Beliakoff is the Executive Director of Oncology Field Medical Affairs at Incyte. His career in Medical Affairs started in 2007, when he joined Berlex as an MSL following a postdoctoral fellowship in Urologic Oncology at Stanford University. Subsequently, he held Medical Science... Read More →
Speakers
avatar for Staci Cohen, MBA

Staci Cohen, MBA

West MSL Director, Rare Disease, Sanofi
Staci Cohen is a dynamic and experienced leader with a robust background in primary and specialty care therapies. She has excelled in regional, and U.S. roles, building markets, launching brands, and managing diverse portfolios. Currently, she serves as the West MSL Director Rare... Read More →
avatar for Rob Consalvo

Rob Consalvo

Senior Director of Strategic Commercial Engagement, H1
Rob Consalvo is Sr. Director of Strategic Commercial Engagement at H1.  He leads a team of client-centric data experts aimed at building unique and valuable insights with external organizations. Rob has enjoyed a decade of work within various commercial organizations spanning multiple... Read More →
avatar for Avni Patel, PharmD

Avni Patel, PharmD

Senior Director, Medical Affairs, Jazz Pharmaceuticals
Thursday September 26, 2024 11:45am - 12:30pm PDT
Grand Ballroom ABCD

12:30pm PDT

Networking Lunch
Thursday September 26, 2024 12:30pm - 1:30pm PDT
Thursday September 26, 2024 12:30pm - 1:30pm PDT
Grand Ballroom salons EFGH

1:30pm PDT

Adapting to Evolving FDA SIUU Guidance: Optimizing Communication Strategies in a Changing Healthcare Landscape
Thursday September 26, 2024 1:30pm - 2:00pm PDT
  • Explore the latest updates and implications of FDA's evolving SIUU guidance and how these changes impact communication strategies for medical affairs teams
  • Examine effective channels and platforms for communicating scientific information under the revised FDA guidance, considering digital tools, publications, and stakeholder engagement
  • Analyze broader trends in healthcare communication and their intersection with FDA SIUU guidance changes.
  • Address the role of medical affairs in adapting to technological advancements, patient-centric approaches, and regulatory expectations in communication strategies
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Thursday September 26, 2024 1:30pm - 2:00pm PDT
Grand Ballroom ABCD
  General Session
  • QTAG MASSW24FS

2:00pm PDT

Driving Patient-Centered Advocacy: Leveraging Real-World Evidence and Clinical Data for Informed Publications and Enhanced Outcomes-
Thursday September 26, 2024 2:00pm - 2:50pm PDT
  • Explore the role of data analytics in shaping customer engagement models and strategies, driving insights to tailor communication approaches and optimize engagement across diverse channels 
  • Discuss methods to streamline content development across multiple channels, ensuring adaptability, effectiveness, and consistency in messaging to enhance customer journey experiences 
  • Delve into practical approaches for implementing omnichannel strategies in scientific communication, navigating the complexities of multi-channel engagement to deliver cohesive and impactful messaging 
Moderators
avatar for Shula Pollard, Ph.D.

Shula Pollard, Ph.D.

Senior Director, Medical Affairs, Viridian Therapeutics
Shula Pollard has diverse experience in the healthcare industry, working in both the medical device and pharmaceutical industries over the last 18 years. She started her career in product management and competitive intelligence, and for the past 10 years has specialized in Medical... Read More →
Speakers
avatar for Ezinneka Imoh, PharmD

Ezinneka Imoh, PharmD

Associate Director, Global Scientific Communications & Medical Education, Chiesi, USA Inc.
Ezinneka is currently an Associate Director, Global Scientific Communications & Medical Education at Chiesi, USA Inc. In this role, she's responsible for the execution of internal and external Medical Education, strategic Scientific Communications & Publications planning and execution... Read More →
avatar for Lynne Gordon, MPH, CMPP, BCMAS

Lynne Gordon, MPH, CMPP, BCMAS

Director, Scientific Communications, Travere Therapeutics
Lynne Gordon, MPH, CMPP, BCMA is a Director, Scientific Communications at Travere Therapeutics; a company who identifies and develops therapies for people living with rare diseases. She has been in the pharmaceutical industry for over 25 years working for both large and small biotech... Read More →
avatar for Elizabeth Hackler, MS, PhD

Elizabeth Hackler, MS, PhD

Executive Director, Scientific Affairs, Axsome Therapeutics
Elizabeth Hackler has broad therapeutic area experience in the pharmaceutical industry, and she has held a variety of positions in Medical Affairs over the last 18 years, in the areas of Publications, Medical Information, Operations, and Field Medical. Elizabeth is currently the Executive... Read More →
avatar for Sharief Taraman, MD, DABPN, DABPM, FAAP

Sharief Taraman, MD, DABPN, DABPM, FAAP

Chief Executive Officer, Cognoa
Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is Chief Executive Officer of Cognoa, a leading pediatric behavioral health and data company developing AI-based technologies to enable early and equitable diagnosis and care for children living with developmental and behavioral health... Read More →
Thursday September 26, 2024 2:00pm - 2:50pm PDT
Grand Ballroom ABCD

2:50pm PDT

Chairperson’s Closing Remarks
Thursday September 26, 2024 2:50pm - 3:00pm PDT
Thursday September 26, 2024 2:50pm - 3:00pm PDT
Grand Ballroom ABCD

3:00pm PDT

Conference Concludes
Thursday September 26, 2024 3:00pm - 3:00pm PDT
Thursday September 26, 2024 3:00pm - 3:00pm PDT
San Diego Marriott Del Mar
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.